BAY 61-3606 dihydrochloride
| Title | Journal |
|---|---|
| Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells. | PloS one 20160101 |
| Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120919 |
| Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells. | Experimental cell research 20120910 |
| ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. | Journal of thrombosis and haemostasis : JTH 20120601 |
| BAY61-3606 affects the viability of colon cancer cells in a genotype-directed manner. | PloS one 20120101 |
| Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cells. | Cellular immunology 20100101 |
| A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. | Proceedings of the National Academy of Sciences of the United States of America 20071218 |
| The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. | The Journal of pharmacology and experimental therapeutics 20030901 |